Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Angélica Nakagawa Lima, Eric Allison Philot, Gustavo Henrique Goulart Trossini, Luis Paulo Barbour Scott, Vinícius Gonçalves Maltarollo & Kathia Maria Honorio. (2016) Use of machine learning approaches for novel drug discovery. Expert Opinion on Drug Discovery 11:3, pages 225-239.
Read now
Read now
Sorin Emilian Leucuta. (2014) Selecting oral bioavailability enhancing formulations during drug discovery and development. Expert Opinion on Drug Discovery 9:2, pages 139-150.
Read now
Read now
Nagasuma Chandra & Jyothi Padiadpu. (2013)
Network approaches to drug discovery
. Expert Opinion on Drug Discovery 8:1, pages 7-20.
Read now
Read now
G. Panagiotou & O. Taboureau. (2012) The impact of network biology in pharmacology and toxicology. SAR and QSAR in Environmental Research 23:3-4, pages 221-235.
Read now
Read now
Nagasuma Chandra. (2011) Computational approaches for drug target identification in pathogenic diseases. Expert Opinion on Drug Discovery 6:10, pages 975-979.
Read now
Read now
Chanin Nantasenamat, Chartchalerm Isarankura-Na-Ayudhya & Virapong Prachayasittikul. (2010) Advances in computational methods to predict the biological activity of compounds. Expert Opinion on Drug Discovery 5:7, pages 633-654.
Read now
Read now
Articles from other publishers (11)
Gabriel Corrêa Veríssimo, Jadson de Castro Gertrudes & Vinícius Gonçalves Maltarollo. 2023. Cheminformatics, QSAR and Machine Learning Applications for Novel Drug Development. Cheminformatics, QSAR and Machine Learning Applications for Novel Drug Development
329
360
.
Kevin Tochukwu Dibia, Philomena Kanwulia Igbokwe, Godfrey Ifechukwu Ezemagu & Christian Oluchukwu Asadu. (2022) Exploration of the quantitative Structure-Activity relationships for predicting Cyclooxygenase-2 inhibition bioactivity by Machine learning approaches. Results in Chemistry 4, pages 100272.
Crossref
Crossref
Tanjore S. Balganesh, Jagadeesh J. Bhat & Bheemarao Ugarkar. 2021. Drug Discovery and Drug Development. Drug Discovery and Drug Development
37
61
.
Gaston K. Mazandu, Emile R. Chimusa, Kayleigh Rutherford, Elsa-Gayle Zekeng, Zoe Z. Gebremariam, Maryam Y. Onifade & Nicola J. Mulder. (2017) Large-scale data-driven integrative framework for extracting essential targets and processes from disease-associated gene data sets. Briefings in Bioinformatics.
Crossref
Crossref
Kristine Kongsbak, Niels Hadrup, Karine Audouze & Anne Marie Vinggaard. (2014) Applicability of Computational Systems Biology in Toxicology. Basic & Clinical Pharmacology & Toxicology 115:1, pages 45-49.
Crossref
Crossref
Pramod Rajaram Somvanshi & K. V. Venkatesh. (2013) A conceptual review on systems biology in health and diseases: from biological networks to modern therapeutics. Systems and Synthetic Biology 8:1, pages 99-116.
Crossref
Crossref
Nagasuma Chandra. 2013. Systems Biology of Tuberculosis. Systems Biology of Tuberculosis
179
192
.
Sean Ekins, Joel S. Freundlich, Inhee Choi, Malabika Sarker & Carolyn Talcott. (2011) Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery. Trends in Microbiology 19:2, pages 65-74.
Crossref
Crossref
Ashwini G. Bhat, Rohit Vashisht & Nagasuma Chandra. (2011) Modeling metabolic adjustment in Mycobacterium tuberculosis upon treatment with isoniazid. Systems and Synthetic Biology 4:4, pages 299-309.
Crossref
Crossref
Dany J.V. BesteJohnjoe McFadden. (2010)
Systems biology of the metabolism of
Mycobacterium tuberculosis
. Biochemical Society Transactions 38:5, pages 1286-1289.
Crossref
Crossref
Dany J. V. Beste & Johnjoe McFadden. (2010) System-level strategies for studying the metabolism of Mycobacterium tuberculosis. Molecular BioSystems 6:12, pages 2363.
Crossref
Crossref